$IMMB "MUST READ" Alright $IMMB Investors and Future

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker

[b]$IMMB[/b] >>>

[b]"MUST READ" [/b]Alright $IMMB Investors and Future Investors here is why I just posted a world of info on HIV/AIDS, To show everyone we are sitting on an [b]ABSOLUTE LIFE CHANGER[/b].

[b]Amazing Website[/b] >> http://www.immunotechlab.com/

[b]As you can see the market here is wide open for growth and by 2018 will consist of a $21 Billion Industry with a steady growth of 7% per annum. [i]More IMPORTANTLY we are in an transition period where MANY current PATENTS will EXPIRE, leaving the door wide open for IMMB[/i]! [/b]

[b]Why is that important to IMMB[/b], there is simply room for Competitors and [b]definite interest for MERGERS/ACQUISITIONS of smaller cap companies. Something in this economy that is happening everyday. [/b]

[b]Well here is my take as to WHY you should BUY IMMB[/b]....

[b]IMMB currently carries a HV/AIDS PATENT valued at over $5 Million [/b]>> http://imagehost.vendio.com/a/8709739/view/Patent.png

So we are in the market. Now we need a game plan, well Dr. Harry Zhabilov worked his ass off for many years using his amazing scientific skills to create a patent...IMMB then realizes they can tap into a Billion Dollar Market with his Patents which for the record we have not one but 4 Patents....Mr.Zhabilov is an amazing Doctor....but he can't do it on his own so [b]on October of 2012 he makes an even more Brilliant move than his Patent Creation, HE SIGNS a contract with Mr. Bo Linton and appointed him to be part of the Board of Directors. [/b]

[b]Well for the people who don't know BO LINTON he has a habit of taking the companies he is involved with to the BIG BOARDS NYSE/NASDAQ)...His last one being MAGNEGAS whom just recently rang the closing bell! [/b]

[b]As of February/2013 IMMB made another BIG move, they appointed Mr. Valentin Dimitrov to the board of directors of the company. Mr. Dimitrov is a CEO of M.T. Rose Corporation also Mr. Dimitrov is one of the owners of the second largest chemical plant in Bulgaria, Europe.[/b]

So now we have a growing Board with TOP notch Members whom carry HUGE connections.

[b]Still with me, well on November 2012 a HUGE NEWS RELEASE Link Provided[/b] >> http://www.otcmarkets.com/stock/IMMB/news

[b]Immunotech Laboratories Inc. Announces Breakthrough Results for HIV and AIDS Treatment for Terminal Salvage Patients [/b]

[b]Followed by a much BIGGER News RELEASE JAN/2013 [/b]Link Provided >> http://www.otcmarkets.com/stock/IMMB/news

[b]Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines[/b]

[b]Which in turn led to THE BIGGEST ONE TO DATE FEB/2013 Link Provided [/b]>> Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender In The Race For HIV & Cancer Cures (link)http://ih.advfn.com/p.php?pid=nmona&article=56128728

If you are still with me you are now adding everything up and saying to yourself HOLY SH*T, [b]We are OFFICIALLY INVOLVED in THAT COVETED BILLION DOLLAR MARKET....and you should be saying IMMB is the MOST UNDERVALUED MEDICAL SCIENCE COMPANY in the OTC soon to be NASDAQ and or NYSE... [/b]

From the last PR and in the words of MR.BO LINTON (read BOLD)>>

Mr. Linton further commented the company recently [b]received an initial inquiry for a significant order of the company's patented HIV vaccine by an International associate for use as an "Experimental Drug[/b]". [i]If confirmed the initial order would be in excess of several Million Dollars.[/i][b] This would expand the company's operations from Research & Development to a Bio-Pharma manufacturing company. In Africa, where approved experimental treatments are permitted, there are approximately 30 Million HIV/AIDS patients alone. [/b]

[b]Now that you are seeing what I am seeing I will show you the KICKER >>

[/b]

[b]CURRENT SHARE STRUCTURE[/b]

OUTSTANDING SHARES 60,500,000 give or take a handful

[b]FLOAT 1 MILLION YES, MILLION (give or take a handful)CONFIRMED Jan.31/2013 in video interview with MR. LINTON [/b](link provided) >> http://www.otcmarkets.com/stock/IMMB/news

Want More, I have more >>

[b]INSIDERS HOLDINGS 98% of O/S Here is the PROOF[/b] >>

Name of Shareholder Number of Shares

Harry Zhabilov 24,895,646 41.11

Ara Ghanime 24,895,646 41.11

Dow Jones Link 2,773,500 4.58

Allie Chang 600,000 1.0

Paul Felizian 600,000 1.0

Lord George Equities 5,400,000 9.0

Joseph Pittera 250,000 0.41

Harout Tovmasyan 151,000 0.25

Elie Sakayan 50,000 0.08

Hagop Parseghian 600,000 1.0

Others 339,896 0.46

So there you have it!

[b]PS since last Wednesday in case you missed it we have seen LESS than 400,000 Shares TRADED or for the most part BOUGHT and we are up from .06 to .35 with MAJOR NEWS PENDING....with that said we have seen MAJOR BIDS UNTOUCHED where investors could have taken HUGE PERCENTAGE GAINS and SIMPLY REFUSED to knowing where IMMB is heading SHORT TERM and or LONG TERM!

[/b]

Good LUCK and REMEMBER only use this as a reference an never spend more than you are willing to lose.

Your Friend Cheeky!

PSS there is more to IMMB than HIV/AIDS Please go to WEBSITE and absorb as much as you can, They are diversified to say the least...link provided above!

Immunotech Laboratories Inc (IMMB) Stock Research Links

IMMB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cascades Eyes New Quebec Govt for Growth Partnerships

Updated Category News Views 3

Quebec's New Ministers: A Fresh Start or the Same Old? So the suits in Quebec have shuffled about and Cascades Inc. (TSX: CAS)—a heavyweight in sustainable papermaking—is polishing their best handshake. They're rolling out the welcome mat for the new ministers in the Government of Quebec. As someone who've seen their fair share of this song and dance, the real...

Continue Reading
Sivers Semiconductors Shakes Up Auditors and Incentives

Updated Category News Views 0

Rethinking the Auditing Game Well, what do you know? Sivers Semiconductors just gave the boot to Deloitte AB. Looks like they're rolling out the welcome mat for Ernst & Young AB to scrutinize their books instead. The move, coming hot from the Extraordinary General Meeting, shows they're not messing around with their financial oversight. Maybe it's a bid for fresh...

Continue Reading
Procede Software Acquires RIMSS: Dealer Tech Shift?

Updated Category News Views 3

Procede's Big Play Seems like Procede Software is tossing the dice with its latest move. The software scene for dealership management is as cutthroat as a New York deli lineup, and now we've got Procede moving to scoop up RIMSS. This isn't just a back-office shuffle; it's a world-rocking maneuver that brings decades of dealer technology know-how into one basket. What's...

Continue Reading
Green Builder Media's Fresh Focus on Net Zero Homes

Updated Category News Views 2

There's a fresh breeze blowing through the building industry, and it's got "net zero" written all over it. Green Builder Media is rolling out a pile of new resources aimed at wrangling this beast of a trend. The focus? High-performance, all-electric homes. And they're not just whispering about it—they've got hard data and practical guidance to back up their claims. Net...

Continue Reading
Mercuryo's Swaps: A New Era in Crypto Trading Flexibility

Updated Category News Views 8

Mercuryo's Bold Leap into Crypto Flexibility Mercuryo thinks they've got this crypto game figured out, tossing a curveball into the market with Swaps. It's like they're saying, "Here, make your moves without the usual headaches." Launched on October 22, 2026, this product lets folks trade between 38 digital tokens and struts out 700 possible trading pairs—and that's...

Continue Reading
Labcorp, FDA Collaborate to Tackle Drug Abuse Risks

Updated Category News Views 3

Rethinking How We Evaluate Drug Abuse Potential Sometimes, the finance world gets a peek into something that ain't just about the numbers on a screen, something with real stakes beyond the bulls and bears. Labcorp's just thrown its hat in with the FDA and Charles River Laboratories in a collaboration that goes beyond just lining pockets. They're setting up to dissect how...

Continue Reading
Granite Gives Pink Raises $583K for Cancer Research

Updated Category News Views 1

Not Just About Numbers: Employee-Led Push for Health If you've ever doubted the power of collective purpose, take a look at Granite Telecommunications' recent endeavor. This hard-hitting telecom giant, with its robust footprint across North America's communication and tech sectors, isn't resting on its laurels when it comes to social responsibility. Their 'Granite Gives...

Continue Reading
CobbleStone & Chu Chua Tech: A Transformative Alliance

Updated Category News Views 2

Breaking Down the CobbleStone and Chu Chua Collaboration We’re in a tough, interconnected world where tech innovation is racing against the clock. So, when CobbleStone Software raises its hand to join forces with Chu Chua Technology Services LLP, it’s like a shot of adrenaline for anyone invested in North America’s tech wave. Let’s pause and dive right in because...

Continue Reading
QFIN Investors Eye Class Action Amid Regulatory Struggles

Updated Category News Views 2

QFIN Shareholders Unite Amid Regulatory Storm It's not every day you see a stock nosedive by nearly 19% overnight. But when you're investing in a company like Qfin Holdings, you get ready for a wild ride, especially when regulatory changes from China come into play. That's exactly what's happening right now as investors rally around a class action lawsuit against Qfin....

Continue Reading
Bambu Lab Shakes Up 3D Printing with Massive Discounts

Updated Category News Views 5

Price Cuts Bring 3D Printing Mainstream Here's the deal—3D printing used to be the domain of the tech-savvy elite, akin to those early computer geeks holed up in garages. But now? Bambu Lab is throwing open those doors with its Black Friday and Cyber Monday specials, slashing prices like a man on a mission. They're bringing an entire technological leap into our hands,...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSyent Reports Impressive Financial Growth in Recent Quarter

Updated Category News Views 143

BioSyent's Financial Performance Overview BioSyent Inc. has recently announced its financial outcomes for the second quarter (Q2) and the first half (H1) of the year, showing promising growth across all sectors. The company, known for its innovative pharmaceutical products, reported notable increases in sales and profit margins. This positive trend reflects its strong...

Continue Reading
MediCapture Unveils Innovative aiScope™ for Veterinary Applications

Updated Category News Views 108

MediCapture Introduces aiScope™ for Veterinary Training Revolutionizing Medical AI CHEROKEE, Texas — MediCapture Inc., recognized for its prowess in medical imaging technology, has announced the exciting launch of aiScope™. This innovative software operates Vision AI models in real-time, directly on selected MediCapture devices, providing tremendous opportunities in...

Continue Reading
EquipmentShare Faces Class Action Over $77M Misconduct

Updated Category News Views 9

Unpacking the EquipmentShare Fiasco Woah, can't say there aren't fireworks going off at EquipmentShare (NASDAQ:EQPT) these days. Lawsuits piling up like pancakes at a Sunday brunch. And guess what? EquipmentShare's stock took a nosedive, shaking retail investors down to their core. This ain't just any bump in the road—it's messy, sticky, and if you're holding $EQPT,...

Continue Reading
BioCryst Pharmaceuticals Welcomes Babar Ghias as CFO

Updated Category News Views 403

Exciting Leadership Change at BioCryst Pharmaceuticals Today, BioCryst Pharmaceuticals, Inc. has announced a significant addition to its leadership team with the appointment of Babar Ghias as Chief Financial Officer (CFO) and head of corporate development. Mr. Ghias will bring to the role a wealth of experience aimed at driving financial strategy and growth within the...

Continue Reading
MMA Digital Corp.: U.S. Banking Infrastructure Playbook

Updated Category Economy Views 30

Getting banking infrastructure right in the United States is genuinely hard. Not hard in a "read more documentation" way. Hard in a "you won't know what you missed until it bites you six months in" way. The U.S. financial system is layered, fragmented, and built on decades of overlapping regulation. For any company trying to move fast, whether entering the market fresh or...

Continue Reading